Fennec Pharmaceuticals Inc. (FENC:NASDAQ) closed at $10.17 on October 26, 2026, up 0.89% on the day. The stock trades 23.2% below its 52-week high of $13.25 and 80.0% above its 52-week low of $5.65. Over the past year, it gained 12.1%. Fennec Pharmaceuticals Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since October 23, 2025, FENC closed higher on 125 days (50%). Its best day was May 14, 2026 (+36.48%) and its worst was March 24, 2026 (-19.19%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 2 times.
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
Find more stocks like FENC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.